...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Vote reminder

One week to the ZCC AGM.

This is your once in a year chance to express your opinion. At RVX Don's "withhold" was over 8%.

Let's make it 20%+ at ZCC.

JMHO

Toinv

Share
New Message
Please login to post a reply